Correlation Between Alector and Lyell Immunopharma
Can any of the company-specific risk be diversified away by investing in both Alector and Lyell Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alector and Lyell Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alector and Lyell Immunopharma, you can compare the effects of market volatilities on Alector and Lyell Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alector with a short position of Lyell Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alector and Lyell Immunopharma.
Diversification Opportunities for Alector and Lyell Immunopharma
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Alector and Lyell is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Alector and Lyell Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyell Immunopharma and Alector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alector are associated (or correlated) with Lyell Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyell Immunopharma has no effect on the direction of Alector i.e., Alector and Lyell Immunopharma go up and down completely randomly.
Pair Corralation between Alector and Lyell Immunopharma
Given the investment horizon of 90 days Alector is expected to generate 0.78 times more return on investment than Lyell Immunopharma. However, Alector is 1.28 times less risky than Lyell Immunopharma. It trades about 0.0 of its potential returns per unit of risk. Lyell Immunopharma is currently generating about -0.02 per unit of risk. If you would invest 920.00 in Alector on July 21, 2024 and sell it today you would lose (421.00) from holding Alector or give up 45.76% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Alector vs. Lyell Immunopharma
Performance |
Timeline |
Alector |
Lyell Immunopharma |
Alector and Lyell Immunopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alector and Lyell Immunopharma
The main advantage of trading using opposite Alector and Lyell Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alector position performs unexpectedly, Lyell Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyell Immunopharma will offset losses from the drop in Lyell Immunopharma's long position.Alector vs. Passage Bio | Alector vs. Black Diamond Therapeutics | Alector vs. Revolution Medicines | Alector vs. Stoke Therapeutics |
Lyell Immunopharma vs. Cullinan Oncology LLC | Lyell Immunopharma vs. Monte Rosa Therapeutics | Lyell Immunopharma vs. Revolution Medicines | Lyell Immunopharma vs. Nkarta Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |